Generic manufacturers are essential players in the fight to end TB so we do speak with generic manufacturers as part of our access strategy.

The WHO said its findings bring into question the validity of studies (performed for 12 products) that are under assessment, but not prequa...

The US Food & Drug Administration has favoured use of FDCs for HIV treatments, but approval process is rigorous.

“The company does not expect significant effect on its top & bottom line since the company have very good presence in Indian and rest of wo...

Following the inspection of it's manufacturing site, European Directorate for the Quality of Medicines and Healthcare has suspended certifi...

The effectiveness of the four-month regimen was proved on the basis of recurrence levels, number of patients testing negative in sputum sme...

The drug combination, known as PaMZ, killed more bacteria than standard treatment and was effective in treating drug-resistant tuberculosis.

March 24 is World TB day. It commemorates the discovery of Tuberculosis (TB) bacillus in 1883 by Dr Robert Koch as the cause of tuberculosi...

Pharma Major, Lupin Ltd today announced that it has entered into an agreement with Farmanguinhos for the supply of its 4 in 1 combination d...

Drug firm Lupin today said it has signed an agreement with Brazil to supply its four-in-one combination drug to treat tuberculosis.

Lupin and Glenmark Pharmaceuticals are leading Indian mid-cap drug makers in exploiting rising demand for medicines in South American natio...